Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 95

Corporate venturing deal net: 23-27 March 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Mar 27, 2020

Letgo links to OfferUp in merger deal

Naspers subsidiary OLX Group led a $120m round for the e-commerce app developers, which have agreed to merge, and will own 40% of the combined entity.

Mar 26, 2020

ZEG Power digs up funding

CCB and CO2 Management came onboard in an $11.3m round for ZEG as it continutes work on its clean hydrogen generation facility.

Mar 25, 2020

City Developments helps build Pupil's funding

Pupil, developer of a spatial analysis system for real estate, raised $16.1m in a round led by property developer City Developments that will fund product development.

Mar 25, 2020

Ping An picks out iCapital in $146m round

The asset management software producer has closed a round led by Ping An Global Voyager Fund with contributions from Goldman Sachs, UBS and BNY Mellon.

Mar 24, 2020

Cazoo motors to $117m

Online used car retailer Cazoo took its overall funding to approximately $218m in a round led by corporate venturing vehicle DMG Ventures.

Mar 24, 2020

Dragonfly Therapeutics drags financing to $300m

Celgene-backed immuno-oncology drug developer Dragonfly Therapeutics boosted its total financing to $300m in round of undisclosed size led by Fidelity.

Mar 24, 2020

Nurix nabs $120m

Celgene-backed Nurix Therapeutics will use the capital to advance two protein modulation-based immuno-oncology drug candidates toward clinical trials.

Mar 23, 2020

Corporate venturing deal net: 16-20 March 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Mar 20, 2020

RemeGen retrieves $100m

The antibody therapy developer closed a $100m round co-led by Lilly Asia Ventures that will fund phase 3 clinical studies for its lead drug candidates.

Mar 18, 2020

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here